Mode
Text Size
Log in / Sign up

Neoadjuvant chemotherapy and surgery can achieve complete pathological response in abdominal aortic angiosarcomaTreatment Options for Rare Tumors After Aortic Aneurysm Repair

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider aortic angiosarcoma in patients with persistent symptoms and atypical periaortic findings after EVAR.

This publication consists of a case report and a review of existing literature regarding patients with abdominal aortic angiosarcoma following endovascular aneurysm repair. The scope of the review is limited, identifying 21 cases of abdominal aortic angiosarcoma following EVAR in the literature.

The authors report one case where neoadjuvant chemotherapy with gemcitabine and docetaxel, radiotherapy, and surgical resection of the abdominal aorta and EVAR graft resulted in a complete pathological response without evidence of residual angiosarcoma. The review highlights the clinical challenge of diagnosing and treating this rare malignancy.

The authors note that there is limited evidence available to guide diagnosis and treatment for this condition. The findings suggest that while surgical and chemotherapeutic interventions can achieve complete pathological response, the rarity of the condition and the small number of reported cases limit the ability to draw broad clinical conclusions. Clinicians should consider aortic angiosarcoma in patients presenting with persistent symptoms and atypical periaortic findings following EVAR.

How this fits prior evidence

This report addresses a gap in the current literature regarding the management of abdominal aortic angiosarcoma following endovascular aneurysm repair. While the prior coverage focused on various oncological treatments such as gemcitabine plus nab-paclitaxel for pancreatic cancer and chemotherapy for esophageal cancer, this report specifically addresses the rare occurrence of angiosarcoma in the context of vascular surgery.

Doctors are looking into a rare type of cancer called angiosarcoma that can develop in the abdominal aorta. This can happen in patients who have already undergone a procedure called endovascular aneurysm repair (EVAR). Because this condition is so rare, there is very little information available to help doctors diagnose and treat it effectively.

A specific case was studied where a patient received a combination of chemotherapy (gemcitabine and docetaxel), radiation, and surgery. This treatment led to a complete pathological response, meaning no evidence of the tumor remained after the procedure. A review of existing medical records identified 21 other cases of this specific tumor following an EVAR procedure.

Because there are so few cases of this condition, the evidence is currently limited. These findings are meant to help doctors recognize the signs of this tumor when a patient has persistent symptoms or unusual findings after their surgery. Patients with these symptoms should speak with their medical team to discuss specific concerns.

What this means for you:
A combination of chemotherapy, radiation, and surgery showed success in one case of a rare aortic tumor.

Common questions

What is angiosarcoma in the abdominal aorta?

Angiosarcoma is a rare type of cancer that can develop in the abdominal aorta. In this study, it was specifically looked at in patients who had already undergone an endovascular aneurysm repair (EVAR). Because it is so rare, there is limited evidence available to guide how doctors diagnose and treat this specific condition.

What treatments were used for this rare tumor?

The study looked at a patient who received neoadjuvant chemotherapy using gemcitabine and docetaxel, along with radiotherapy. They also underwent surgical resection of the abdominal aorta and the graft. This combination of treatments resulted in a complete pathological response with no remaining evidence of the tumor.

How common is this condition after surgery?

This condition is very rare. The analysis of existing literature identified only 21 reported cases of abdominal aortic angiosarcoma following an EVAR procedure. Because of these low numbers, doctors must be extra vigilant when patients show persistent symptoms or atypical findings after their surgery.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
Abdominal aortic angiosarcoma following endovascular aneurysm repair (EVAR) is an exceptionally rare and aggressive malignancy that may mimic common EVAR-related complications. We report the case of a 72-year-old man who presented with progressive lower back pain and was initially suspected of having a graft infection. Imaging revealed a periaortic mass involving a previously treated abdominal aortic aneurysm. Biopsy confirmed aortic angiosarcoma. No regional lymph node or distant metastases were identified. The patient underwent neoadjuvant chemotherapy with gemcitabine and docetaxel, followed by radiotherapy and surgical resection of the abdominal aorta and EVAR graft with aortic reconstruction. Histopathological examination demonstrated complete pathological response without evidence of residual angiosarcoma. Our literature review identified only 21 reported cases of abdominal aortic angiosarcoma following EVAR, including the present case, underscoring the exceptional rarity of this entity and the limited evidence available to guide diagnosis and treatment. This case highlights the importance of considering aortic angiosarcoma in patients with persistent symptoms and atypical periaortic findings after EVAR and suggests that early biopsy and a multidisciplinary, multimodal treatment approach may improve outcomes despite the generally poor prognosis associated with this disease.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.